Skip to main content
Top
Published in: Applied Health Economics and Health Policy 4/2013

01-08-2013 | Original Research Article

Explaining the Health Costs Associated with Managing Intracranial Aneurysms in Italy

Authors: Stefano Calciolari, Aleksandra Torbica, Rosanna Tarricone

Published in: Applied Health Economics and Health Policy | Issue 4/2013

Login to get access

Abstract

Background

The clinical management of intracranial aneurysms is debated in many countries because of the associated disability risk and costs. Therefore, estimating the costs and explaining their variability will provide important information for decision makers.

Objective

We aimed to evaluate the acute and post-acute health costs of intracranial aneurysm management and to explain the variability in these costs in the Italian National Health System.

Methods

An observational study was conducted on 145 patients who were affected by a (single) ruptured or an unruptured intracranial aneurysm. They were consecutively admitted to 14 Italian hospitals between October 2005 and March 2007. The data collected during the initial hospitalization and three follow-up visits were used to assess the 1-year health costs and the patients’ health status after discharge. Two multivariate regression models were used to explain the variability in the acute and post-acute costs.

Results

The average total cost per patient was €30,813 (evaluation year: 2012). The first model explained the acute costs fairly well and showed that the severity of illness, the admission unit (i.e., intensive care unit vs. another unit of the hospital), and mortality were associated with large, significant (p < 0.05) coefficients. The second model outperformed the first one in explaining the post-acute costs and showed that health status assessed 30 days after discharge was a significant (p < 0.05) predictor of costs.

Conclusion

Policies aimed at containing health costs should focus on interventions that help to reduce disability, which is a key predictor of long-term costs.
Appendix
Available only for authorised users
Footnotes
1
ICU versus another unit in the hospital.
 
2
The mRS is a disease-specific scale that is widely used with stroke patients to define clinically discrete disability categories. This outcome measure does not include the ‘death’ status.
 
3
The model explains about 48 % of the variability by including the health status assessed 12 months after discharge, though this time period would make the model’s estimates strictly retrospective.
 
4
We refer to discharge records of the Ministry of Health (http://​www.​salute.​gov.​it).
 
Literature
2.
go back to reference Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27(13):1610–9.PubMedCrossRef Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27(13):1610–9.PubMedCrossRef
3.
go back to reference Laloux P. Cost of acute stroke: a review. Acta Neurol Belg. 2003;103(2):71–7.PubMed Laloux P. Cost of acute stroke: a review. Acta Neurol Belg. 2003;103(2):71–7.PubMed
4.
go back to reference Payne KA, Huybrechts KF, Caro JJ, Craig Green TJ, Klittich WS. Long term cost-of-illness in stroke: an international review. Pharmacoeconomics. 2002;20(12):813–25.PubMedCrossRef Payne KA, Huybrechts KF, Caro JJ, Craig Green TJ, Klittich WS. Long term cost-of-illness in stroke: an international review. Pharmacoeconomics. 2002;20(12):813–25.PubMedCrossRef
5.
go back to reference Evers SM, Struijs JN, Ament AJ, van Genugten ML, Jager JH, van den Bos GA. International comparison of stroke cost studies. Stroke. 2004;35(5):1209–15.PubMedCrossRef Evers SM, Struijs JN, Ament AJ, van Genugten ML, Jager JH, van den Bos GA. International comparison of stroke cost studies. Stroke. 2004;35(5):1209–15.PubMedCrossRef
6.
go back to reference Dawson J, Lees JS, Chang TP, Walters MR, Ali M, Davis SM, et al. Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke. 2007;38(6):1893–8.PubMedCrossRef Dawson J, Lees JS, Chang TP, Walters MR, Ali M, Davis SM, et al. Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke. 2007;38(6):1893–8.PubMedCrossRef
7.
go back to reference Spieler JF, Lanoe JL, Amarenco P. Costs of stroke care according to handicap levels and stroke subtypes. Cerebrovasc Dis. 2004;17(2–3):134–42.PubMedCrossRef Spieler JF, Lanoe JL, Amarenco P. Costs of stroke care according to handicap levels and stroke subtypes. Cerebrovasc Dis. 2004;17(2–3):134–42.PubMedCrossRef
8.
go back to reference Spratt N, Wang Y, Levi C, Ng K, Evans M, Fisher J. A prospective study of predictors of prolonged hospital stay and disability after stroke. J Clin Neurosci. 2003;10(6):665–9.PubMedCrossRef Spratt N, Wang Y, Levi C, Ng K, Evans M, Fisher J. A prospective study of predictors of prolonged hospital stay and disability after stroke. J Clin Neurosci. 2003;10(6):665–9.PubMedCrossRef
9.
go back to reference Christensen MC, Morris S. Association between disability measures and short-term health care costs following intracerebral hemorrhage. Neurocrit Care. 2008;9(3):313–8.PubMedCrossRef Christensen MC, Morris S. Association between disability measures and short-term health care costs following intracerebral hemorrhage. Neurocrit Care. 2008;9(3):313–8.PubMedCrossRef
10.
go back to reference Rinkel GJE, Djibuti M, Algra A, Van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29:251–6.PubMedCrossRef Rinkel GJE, Djibuti M, Algra A, Van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29:251–6.PubMedCrossRef
11.
go back to reference Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF. Treatment of unruptured intracranial aneurysms: a nationwide assessment of effectiveness. Am J Neuroradiol. 2007;28:146–51.PubMed Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF. Treatment of unruptured intracranial aneurysms: a nationwide assessment of effectiveness. Am J Neuroradiol. 2007;28:146–51.PubMed
12.
go back to reference Dodel R, Winter Y, Ringel F, Spottke A, Gharevi N, Müller I, et al. Cost of illness in subarachnoid hemorrhage: a German longitudinal study. Stroke. 2010;41(12):2918–23.PubMedCrossRef Dodel R, Winter Y, Ringel F, Spottke A, Gharevi N, Müller I, et al. Cost of illness in subarachnoid hemorrhage: a German longitudinal study. Stroke. 2010;41(12):2918–23.PubMedCrossRef
13.
go back to reference Raja PV, Huang J, Germanwala AV, Gailloud P, Murphy KP, Tamargo RJ. Microsurgical clipping and endovascular coiling of intracranial aneurysms: a critical review of the literature. Neurosurgery 2008;62(6):1187–202; discussion 202–3. Raja PV, Huang J, Germanwala AV, Gailloud P, Murphy KP, Tamargo RJ. Microsurgical clipping and endovascular coiling of intracranial aneurysms: a critical review of the literature. Neurosurgery 2008;62(6):1187–202; discussion 202–3.
14.
go back to reference Birkmeyer J, Siewers A, Finlayson E, Stukel T, Lucas F, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–37.PubMedCrossRef Birkmeyer J, Siewers A, Finlayson E, Stukel T, Lucas F, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–37.PubMedCrossRef
15.
go back to reference Tarricone R. Cost-of-illness analysis: what room in health economics. Health Policy. 2006;77(1):51–63.PubMedCrossRef Tarricone R. Cost-of-illness analysis: what room in health economics. Health Policy. 2006;77(1):51–63.PubMedCrossRef
16.
go back to reference Roos YBWEM, Dijkgraaf MGW, Albrecht KW, Beenen LFM, Groen RJM, De Haan RJ, et al. Direct costs of modern treatment of aneurysmal subarachnoid haemorrhage in the first year after diagnosis. Stroke. 2002;33:1595–9.PubMedCrossRef Roos YBWEM, Dijkgraaf MGW, Albrecht KW, Beenen LFM, Groen RJM, De Haan RJ, et al. Direct costs of modern treatment of aneurysmal subarachnoid haemorrhage in the first year after diagnosis. Stroke. 2002;33:1595–9.PubMedCrossRef
17.
go back to reference Caro JJ, Huybrechts KF, Kelley HE. Predicting treatment costs after acute ischemic stroke on the basis of patient characteristics at presentation and early dysfunction. Stroke. 2001;32:100–6.PubMedCrossRef Caro JJ, Huybrechts KF, Kelley HE. Predicting treatment costs after acute ischemic stroke on the basis of patient characteristics at presentation and early dysfunction. Stroke. 2001;32:100–6.PubMedCrossRef
18.
go back to reference Marques de Sa J. Applied statistics using SPSS, STATISTICA and MATLAB. Berlin: Springer; 2003. Marques de Sa J. Applied statistics using SPSS, STATISTICA and MATLAB. Berlin: Springer; 2003.
19.
go back to reference Fox J. Applied regression analysis, linear models and related methods. Thousand Oaks: Sage; 1997. Fox J. Applied regression analysis, linear models and related methods. Thousand Oaks: Sage; 1997.
20.
go back to reference Zivot E, Wang J. Modelling financial time series with S-PLUS. Boston: Birkhauser; 2006. Zivot E, Wang J. Modelling financial time series with S-PLUS. Boston: Birkhauser; 2006.
21.
go back to reference Baum C. An introduction to modern econometrics using Stata. College Station: Stata Press; 2006. Baum C. An introduction to modern econometrics using Stata. College Station: Stata Press; 2006.
22.
go back to reference White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48(4):817–38.CrossRef White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48(4):817–38.CrossRef
23.
go back to reference Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005;24(3):465–88.PubMedCrossRef Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005;24(3):465–88.PubMedCrossRef
24.
go back to reference Manning WG, Mullahy J. Estimating log models: to transform or not to transform. J Health Econ. 2001;20(4):461–94.PubMedCrossRef Manning WG, Mullahy J. Estimating log models: to transform or not to transform. J Health Econ. 2001;20(4):461–94.PubMedCrossRef
25.
go back to reference Buccoliero L, Calciolari S, Marsilio M. A methodological and operative framework for the evaluation of an e-health project. Int J Health Plan Manag. 2008;23(1):3–20.CrossRef Buccoliero L, Calciolari S, Marsilio M. A methodological and operative framework for the evaluation of an e-health project. Int J Health Plan Manag. 2008;23(1):3–20.CrossRef
26.
go back to reference Drummond M, Griffin A, Tarricone R. Economic evaluation for devices and drugs—same or different? Value Health. 2009;12(4):402–4.PubMedCrossRef Drummond M, Griffin A, Tarricone R. Economic evaluation for devices and drugs—same or different? Value Health. 2009;12(4):402–4.PubMedCrossRef
27.
go back to reference Fattore G, Torbica A. Economic evaluation in health care: the point of view of informed physicians. Value Health. 2006;9(3):157–67.PubMedCrossRef Fattore G, Torbica A. Economic evaluation in health care: the point of view of informed physicians. Value Health. 2006;9(3):157–67.PubMedCrossRef
28.
go back to reference Sorenson C, Tarricone R, Siebert M, Drummond M. Applying health economics for policy decision making: do devices differ from drugs? Europace. 2011;13(Suppl 2):1154–8.CrossRef Sorenson C, Tarricone R, Siebert M, Drummond M. Applying health economics for policy decision making: do devices differ from drugs? Europace. 2011;13(Suppl 2):1154–8.CrossRef
29.
go back to reference Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet. 2011;377(9765):529–32.PubMedCrossRef Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet. 2011;377(9765):529–32.PubMedCrossRef
30.
go back to reference Ciani O, Tarricone R, Torbica A. Diffusion and use of health technology assessment in policy making: What lessons for decentralised healthcare systems? Health Policy. 2012;108(2-3):194-202. Ciani O, Tarricone R, Torbica A. Diffusion and use of health technology assessment in policy making: What lessons for decentralised healthcare systems? Health Policy. 2012;108(2-3):194-202.
Metadata
Title
Explaining the Health Costs Associated with Managing Intracranial Aneurysms in Italy
Authors
Stefano Calciolari
Aleksandra Torbica
Rosanna Tarricone
Publication date
01-08-2013
Publisher
Springer International Publishing
Published in
Applied Health Economics and Health Policy / Issue 4/2013
Print ISSN: 1175-5652
Electronic ISSN: 1179-1896
DOI
https://doi.org/10.1007/s40258-013-0041-1

Other articles of this Issue 4/2013

Applied Health Economics and Health Policy 4/2013 Go to the issue